Senior Communications Manager
Brian Pandya Discusses Supreme Court Patent Ruling in Teva v. Sandoz
Brian H. Pandya, a partner in Wiley Rein’s Intellectual Property and Litigation practices, was quoted by Bloomberg News in a January 20 article discussing the ruling by the Supreme Court of the United States in Teva Pharmaceuticals USA Inc. et al. v. Sandoz Inc. et al. concerning the standard of review for claim constructions. The article was picked up by the Chicago Tribune and the San Francisco news site SFGate.
Mr. Pandya’s commentary discussed how the Supreme Court’s ruling altered long-standing practices in claim construction.
He was also quoted in Bloomberg BNA. To read the article, click here.